Literature DB >> 10365750

The sensitivity and specificity of commercial reagents for the detection of lupus anticoagulant show marked differences in performance between photo-optical and mechanical coagulometers.

A S Lawrie1, I J Mackie, G Purdy, S J Machin.   

Abstract

This study was undertaken to appraise the application of those reagents most widely used in the UK for the detection and confirmation of lupus anticoagulant (LA) on an Amelung KC4A and a Sysmex CA-6000 coagulometer. Five sets of dilute Russell's viper venom time (DRVVT) reagents were assessed as well as the Textarin-PL/ Ecarin ratio. Each DRVVT method comprised both LA detection and confirmation reagents provided by the same manufacturer. Samples were obtained from 20 normal healthy subjects, 10 LA-positive patients, 10 patients receiving oral anticoagulant therapy (OAT) who had previously been documented as LA-positive, a further 10 LA-negative patients receiving OAT and 10 LA-negative patients receiving unfractionated heparin therapy. The sensitivity and specificity of the reagents exhibited considerable variation not only between reagents, but also when the same reagent was used on the two analysers. Sensitivity ranged from 62 to 97% (all reagents both analysers), specificity went as low as 23% (Gradipore reagent on the CA-6000) and as high as 100% (American Diagnostica Inc on both KC4A and CA-6000). On the KC4A instrument, Unicorn Diagnostics' lupus anticoagulant kit offered the best compromise of sensitivity and specificity (sensitivity 83% and specificity 81%). On the CA-6000 the reagents supplied by American Diagnostica Inc exhibited optimal performance (sensitivity 90% and specificity 100%). The results indicate a need to optimise test reagents for specific analyser types, a procedure which can only be undertaken with preparations such as the proposed NIBSC reference plasmas for the detection of lupus anticoagulant.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10365750

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  8 in total

Review 1.  The epidemiology of the antiphospholipid syndrome: who is at risk?

Authors:  G Finazzi
Journal:  Curr Rheumatol Rep       Date:  2001-08       Impact factor: 4.592

2.  Clinical usefulness of the dilute Russell viper venom time test for patients taking warfarin.

Authors:  Kazunori Kanouchi; Hiroto Narimatsu; Okio Ohnuma; Keita Morikane; Akira Fukao
Journal:  Int J Hematol       Date:  2017-04-07       Impact factor: 2.490

Review 3.  The enigmas of the lupus anticoagulant: mechanisms, diagnosis, and management.

Authors:  Richard A Marlar; Sanam Husain
Journal:  Curr Rheumatol Rep       Date:  2008-01       Impact factor: 4.592

Review 4.  Treatment and monitoring of patients with antiphospholipid antibodies and thrombotic history (Hughes syndrome).

Authors:  Maria J Cuadrado
Journal:  Curr Rheumatol Rep       Date:  2002-10       Impact factor: 4.592

5.  Detection and quantification of lupus anticoagulants in plasma from heparin treated patients, using addition of polybrene.

Authors:  Eva M Jacobsen; Elin J Trettenes; Finn Wisløff; Ulrich Abildgaard
Journal:  Thromb J       Date:  2006-01-25

6.  How to Achieve Standardization? Diluted Russell Viper Venom Test for Lupus Anticoagulant Detection in a Chinese Female Population.

Authors:  Feng Lu; Qingkai Dai; Yuefang Wang; Xia Zhang; Ge Zhang
Journal:  Clin Appl Thromb Hemost       Date:  2021 Jan-Dec       Impact factor: 2.389

7.  Combining Taipan snake venom time/Ecarin time screening with the mixing studies of conventional assays increases detection rates of lupus anticoagulants in orally anticoagulated patients.

Authors:  Gary W Moore
Journal:  Thromb J       Date:  2007-09-06

8.  Application of different lupus anticoagulant diagnostic algorithms to the same assay data leads to interpretive discrepancies in some samples.

Authors:  Gary W Moore; James C Maloney; Naomi de Jager; Clare L Dunsmore; Dervilla K Gorman; Richard F Polgrean; Maria L Bertolaccini
Journal:  Res Pract Thromb Haemost       Date:  2017-06-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.